MindImmune Therapeutics


MindImmune Therapeutics, Inc. is a pharmaceutical company developing first-in-class drugs that target the immune system to treat diseases of the central nervous system, including Alzheimer’s and Huntington’s disease, pain, and psychiatric disorders.

Industries

Employees

1-10

Links


Org chart

Stevin Zorn
President & CEO
Collapse
Frank S. Menniti
Chief Science Officer

Board & advisors



Offices